RATIONALE: Aberrant regulation of airway epithelial cell numbers in airways leads to increased mucous secretions in chronic lung diseases such as chronic bronchitis. Because the Bcl-2 family of proteins is crucial for airway epithelial homeostasis, identifying the players that reduce cigarette smoke (CS)-induced mucous cell metaplasia can help to develop effective therapies. OBJECTIVES: To identify the Bcl-2 family of proteins that play a role in reducing CS-induced mucous cell metaplasia. METHODS: We screened for dysregulated expression of the Bcl-2 family members. MEASUREMENTS AND MAIN RESULTS: We identified Bik to be significantly reduced in bronchial brushings of patients with chronic epithelial cell hyperplasia compared with nondiseased control subjects. Reduced Bik but increased MUC5AC mRNA levels were also detected when normal human airway epithelial cells (HAECs) were exposed to CS or when autopsy tissues from former smokers with and without chronic bronchitis were compared. Similarly, exposure of C57Bl/6 mice to CS resulted in increased numbers of epithelial and mucous cells per millimeter of basal lamina, along with reduced Bik but increased Muc5ac expression, and this change was sustained even when mice were allowed to recover in filtered air for 8 weeks. Restoring Bik expression significantly suppressed CS-induced mucous cell metaplasia in differentiated primary HAEC cultures and in airways of mice in vivo. Bik blocked nuclear translocation of phospho-ERK1/2 to induce apoptosis of HAECs. The conserved Leu61 within Bik and ERK1/2 activation were essential to induce cell death in hyperplastic mucous cells. CONCLUSIONS: These studies show that CS suppresses Bik expression to block airway epithelia cell death and thereby increases epithelial cell hyperplasia in chronic bronchitis.
RATIONALE: Aberrant regulation of airway epithelial cell numbers in airways leads to increased mucous secretions in chronic lung diseases such as chronic bronchitis. Because the Bcl-2 family of proteins is crucial for airway epithelial homeostasis, identifying the players that reduce cigarette smoke (CS)-induced mucous cell metaplasia can help to develop effective therapies. OBJECTIVES: To identify the Bcl-2 family of proteins that play a role in reducing CS-induced mucous cell metaplasia. METHODS: We screened for dysregulated expression of the Bcl-2 family members. MEASUREMENTS AND MAIN RESULTS: We identified Bik to be significantly reduced in bronchial brushings of patients with chronic epithelial cell hyperplasia compared with nondiseased control subjects. Reduced Bik but increased MUC5AC mRNA levels were also detected when normal human airway epithelial cells (HAECs) were exposed to CS or when autopsy tissues from former smokers with and without chronic bronchitis were compared. Similarly, exposure of C57Bl/6 mice to CS resulted in increased numbers of epithelial and mucous cells per millimeter of basal lamina, along with reduced Bik but increased Muc5ac expression, and this change was sustained even when mice were allowed to recover in filtered air for 8 weeks. Restoring Bik expression significantly suppressed CS-induced mucous cell metaplasia in differentiated primary HAEC cultures and in airways of mice in vivo. Bik blocked nuclear translocation of phospho-ERK1/2 to induce apoptosis of HAECs. The conserved Leu61 within Bik and ERK1/2 activation were essential to induce cell death in hyperplastic mucous cells. CONCLUSIONS: These studies show that CS suppresses Bik expression to block airway epithelia cell death and thereby increases epithelial cell hyperplasia in chronic bronchitis.
Authors: Yohannes Tesfaigzi; Mark J Fischer; Massoud Daheshia; Francis H Y Green; George T De Sanctis; Julie A Wilder Journal: J Immunol Date: 2002-11-15 Impact factor: 5.422
Authors: Ante S Lundberg; Scott H Randell; Sheila A Stewart; Brian Elenbaas; Kimberly A Hartwell; Mary W Brooks; Mark D Fleming; John C Olsen; Scott W Miller; Robert A Weinberg; William C Hahn Journal: Oncogene Date: 2002-07-04 Impact factor: 9.867
Authors: Silke Radetzki; Claus-Henning Köhne; Clarissa von Haefen; Bernhard Gillissen; Isrid Sturm; Bernd Dörken; Peter T Daniel Journal: Oncogene Date: 2002-01-10 Impact factor: 9.867
Authors: C J Torrance; P E Jackson; E Montgomery; K W Kinzler; B Vogelstein; A Wissner; M Nunes; P Frost; C M Discafani Journal: Nat Med Date: 2000-09 Impact factor: 53.440
Authors: Zha O-Quan Shi; Mark J Fischer; George T De Sanctis; Mark R Schuyler; Yohannes Tesfaigzi Journal: J Immunol Date: 2002-05-01 Impact factor: 5.422
Authors: Yohannes A Mebratu; Jennifer Tipper; Hitendra S Chand; Stephanie Walton; Kevin S Harrod; Yohannes Tesfaigzi Journal: Am J Respir Cell Mol Biol Date: 2016-05 Impact factor: 6.914
Authors: Shuguang Leng; Christine A Stidley; Yushi Liu; Christopher K Edlund; Randall P Willink; Younghun Han; Maria Teresa Landi; Michael Thun; Maria A Picchi; Shannon E Bruse; Richard E Crowell; David Van Den Berg; Neil E Caporaso; Christopher I Amos; Jill M Siegfried; Yohannes Tesfaigzi; Frank D Gilliland; Steven A Belinsky Journal: Cancer Res Date: 2011-12-02 Impact factor: 12.701
Authors: Mathewos Tessema; Dereje D Tassew; Christin M Yingling; Kieu Do; Maria A Picchi; Guodong Wu; Hans Petersen; Scott Randell; Yong Lin; Steven A Belinsky; Yohannes Tesfaigzi Journal: Lung Cancer Date: 2020-05-25 Impact factor: 5.705